| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |